DE3864210D1 - Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden. - Google Patents

Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.

Info

Publication number
DE3864210D1
DE3864210D1 DE8888201240T DE3864210T DE3864210D1 DE 3864210 D1 DE3864210 D1 DE 3864210D1 DE 8888201240 T DE8888201240 T DE 8888201240T DE 3864210 T DE3864210 T DE 3864210T DE 3864210 D1 DE3864210 D1 DE 3864210D1
Authority
DE
Germany
Prior art keywords
complaints
treating
climate
prevention
dosing unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888201240T
Other languages
English (en)
Inventor
Lambert Joseph Wilhelm Mar Tax
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE3864210D1 publication Critical patent/DE3864210D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE8888201240T 1987-07-06 1988-06-20 Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden. Expired - Fee Related DE3864210D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701586 1987-07-06

Publications (1)

Publication Number Publication Date
DE3864210D1 true DE3864210D1 (de) 1991-09-19

Family

ID=19850262

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888201240T Expired - Fee Related DE3864210D1 (de) 1987-07-06 1988-06-20 Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.

Country Status (12)

Country Link
US (1) US4914089A (de)
EP (1) EP0300523B1 (de)
JP (1) JPS6429314A (de)
KR (1) KR950010156B1 (de)
AT (1) ATE66149T1 (de)
AU (1) AU611168B2 (de)
CA (1) CA1313622C (de)
DE (1) DE3864210D1 (de)
DK (1) DK376188A (de)
ES (1) ES2024010B3 (de)
GR (1) GR3003104T3 (de)
ZA (1) ZA884418B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0496520A1 (de) * 1991-01-22 1992-07-29 Merck & Co. Inc. Knochenaktive Verbindungen
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL113816A (en) 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
USD731568S1 (en) * 2013-08-01 2015-06-09 Sejong Pharmatech Co., Ltd. Compression molding machine for tablets
USD741386S1 (en) * 2013-09-13 2015-10-20 Carefusion Germany 326 Gmbh Machine for packaging dosed quantities of solid drug portions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (de) * 1966-11-02 1968-05-03
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
GB8617560D0 (en) * 1986-07-18 1986-08-28 Raychem Gmbh Cable connector

Also Published As

Publication number Publication date
GR3003104T3 (en) 1993-02-17
ZA884418B (en) 1990-02-28
ATE66149T1 (de) 1991-08-15
US4914089A (en) 1990-04-03
JPS6429314A (en) 1989-01-31
DK376188A (da) 1989-01-07
ES2024010B3 (es) 1992-02-16
KR890001564A (ko) 1989-03-27
EP0300523B1 (de) 1991-08-14
AU1866888A (en) 1989-01-12
KR950010156B1 (en) 1995-09-11
EP0300523A1 (de) 1989-01-25
DK376188D0 (da) 1988-07-06
CA1313622C (en) 1993-02-16
AU611168B2 (en) 1991-06-06

Similar Documents

Publication Publication Date Title
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3484416D1 (de) Intraalveolare vorrichtung zur verabreichung von wirkstoffen zum behandeln periodontaler krankheiten.
DE3864210D1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
DE3773442D1 (de) Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit.
NO161035C (no) Fluoridtilsatte artikler for tannbehandling.
DE3888809D1 (de) Gerät zur Verdampfung von Desinfektionsmitteln.
DE3579151D1 (de) Vorrichtung zur behandlung der oberschenkelknochenbrueche.
DE3867736D1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
NL188501C (nl) Harsachtige samenstelling voor een tandheelkundige toepassing.
AT372600B (de) Vorrichtung zur abgabe von pflegemittel an aerztliche, insbesondere zahnaerztliche handstuecke
DE3861977D1 (de) Vorrichtung zur dosierbaren klebstoff-applikation.
DE58906881D1 (de) Gerät zur Zahnbehandlung.
DE58904328D1 (de) Verfahren zur desinfektion von medizinischen abformmassen.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
NO882559L (no) Transdermalt leveringssystem for farmasoeytiske forbindelser.
ES2019634B3 (es) Terapia con clorfeniramina.
ATE194775T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen
DE3382392D1 (de) Dosierungsart zur dauerhaften verabreichung von chinidin.
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
ATE86481T1 (de) Dosisform zur verabreichung von calciumantagonisten.
DE3888354D1 (de) Vorrichtung zur beseitigung von zahnläsionen.
DE68905343D1 (de) Dosisform zur verabreichung von calciumantagonisten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee